0001888097-21-000001.txt : 20211014 0001888097-21-000001.hdr.sgml : 20211014 20211014113430 ACCESSION NUMBER: 0001888097-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211014 DATE AS OF CHANGE: 20211014 EFFECTIVENESS DATE: 20211014 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Fleet Therapeutics, Inc. CENTRAL INDEX KEY: 0001888097 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-416918 FILM NUMBER: 211322823 BUSINESS ADDRESS: STREET 1: 6 TIDE STREET, SUITE C, LAB C CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 857-305-1825 MAIL ADDRESS: STREET 1: 6 TIDE STREET, SUITE C, LAB C CITY: BOSTON STATE: MA ZIP: 02110 D 1 primary_doc.xml X0708 D LIVE 0001888097 Fleet Therapeutics, Inc. 6 TIDE STREET, SUITE C, LAB C BOSTON MA MASSACHUSETTS 02110 857-305-1825 DELAWARE None None Corporation true 2019 Deborah Palestrant 6 Tide Street, Suite C, Lab C Boston MA MASSACHUSETTS 02110 Executive Officer Director Other Decline to Disclose 06b false 2021-09-16 false true false 0 58100470 24100475 33999995 false 4 0 0 0 false Fleet Therapeutics, Inc. /s/ Deborah Palestrant Deborah Palestrant Chief Executive Officer 2021-09-30